Kamil Tamiola is the founder of Peptone. Peptone has raised $42M in total funding. Latest round: Series A. Based in London, UK.
Kamil Tamiola is the founder of Peptone, a health tech company that develops therapeutics against intrinsically disordered proteins. Peptone utilizes a unique drug discovery platform that combines generative protein AI and advanced biophysical experiments. The company has raised a total of $42.4 million in funding, including a $40 million Series A round in June 2022. Peptone's algorithmic engine runs on a supercomputer built with NVIDIA.
Full founder directory · Investor directory · Company funding database · Fundraising library